Ugurel S - Search Results

1

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis.

Koch EAT, Petzold A, Wessely A, Dippel E, Gesierich A, Gutzmer R, Hassel JC, Haferkamp S, Hohberger B, Kähler KC, Knorr H, Kreuzberg N, Leiter U, Loquai C, Meier F, Meissner M, Mohr P, Pföhler C, Rahimi F, Schadendorf D, Schell B, Schlaak M, Terheyden P, Thoms KM, Schuler-Thurner B, Ugurel S, Ulrich J, Utikal J, Weichenthal M, Ziller F, Berking C, Heppt MV, On Behalf Of The German Dermatologic Cooperative Oncology Group DeCOG Committee Ocular Melanoma. Koch EAT, et al. Among authors: ugurel s. Cancers (Basel). 2021 Jul 4;13(13):3359. doi: 10.3390/cancers13133359. Cancers (Basel). 2021. PMID: 34283061 Free PMC article.

2

Successful treatment of progressive vitiligo with high-dose intravenous methylprednisolone 'pulse' therapy.

Seiter S, Ugurel S, Pföhler C, Tilgen W, Reinhold U. Seiter S, et al. Among authors: ugurel s. Dermatology. 1999;199(3):261-2. doi: 10.1159/000018260. Dermatology. 1999. PMID: 10592410

3

Interferon-alpha-associated development of bullous lesions in mycosis fungoides.

Pföhler C, Ugurel S, Seiter S, Wagner A, Tilgen W, Reinhold U. Pföhler C, et al. Among authors: ugurel s. Dermatology. 2000;200(1):51-3. doi: 10.1159/000018317. Dermatology. 2000. PMID: 10681616

4

Dose-dependent severe cutaneous reactions to imatinib.

Ugurel S, Hildenbrand R, Dippel E, Hochhaus A, Schadendorf D. Ugurel S, et al. Br J Cancer. 2003 Apr 22;88(8):1157-9. doi: 10.1038/sj.bjc.6600893. Br J Cancer. 2003. PMID: 12698177 Free PMC article.

5

Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study.

Pföhler C, Cree IA, Ugurel S, Kuwert C, Haass N, Neuber K, Hengge U, Corrie PG, Zutt M, Tilgen W, Reinhold U. Pföhler C, et al. Among authors: ugurel s. Anticancer Drugs. 2003 Jun;14(5):337-40. doi: 10.1097/00001813-200306000-00002. Anticancer Drugs. 2003. PMID: 12782938 Clinical Trial.

6

Systemic treatment in advanced melanoma: innovative perspectives.

Ugurel S, Schadendorf D. Ugurel S, et al. Onkologie. 2003 Jun;26(3):234-8. doi: 10.1159/000071618. Onkologie. 2003. PMID: 12845207 Review.

7

Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma.

Pföhler C, Haus A, Palmowski A, Ugurel S, Ruprecht KW, Thirkill CE, Tilgen W, Reinhold U. Pföhler C, et al. Among authors: ugurel s. Br J Dermatol. 2003 Jul;149(1):74-8. doi: 10.1046/j.1365-2133.2003.05377.x. Br J Dermatol. 2003. PMID: 12890197

8

Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients.

Ugurel S, Uhlig D, Pföhler C, Tilgen W, Schadendorf D, Reinhold U. Ugurel S, et al. Cancer Immunol Immunother. 2004 Jun;53(6):551-9. doi: 10.1007/s00262-003-0489-1. Epub 2004 Jan 16. Cancer Immunol Immunother. 2004. PMID: 14727087 Free PMC article.

9

Altered surface expression patterns of circulating monocytes in cancer patients: impaired capacity of T-cell stimulation?

Ugurel S, Lindemann M, Schadendorf D, Grosse-Wilde H. Ugurel S, et al. Cancer Immunol Immunother. 2004 Nov;53(11):1051. doi: 10.1007/s00262-004-0565-1. Epub 2004 Jun 30. Cancer Immunol Immunother. 2004. PMID: 15232653 Free PMC article. No abstract available.

10

Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma.

Fink W, Zimpfer-Rechner C, Thoelke A, Figl R, Kaatz M, Ugurel S, Schadendorf D. Fink W, et al. Among authors: ugurel s. Onkologie. 2004 Dec;27(6):540-4. doi: 10.1159/000081335. Onkologie. 2004. PMID: 15591712 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

303 results

Search Page